Business · 23/05/2014
FDA Releases Guidance on Transferring Clinical Investigation Oversight
The FDA has published a guidance document outlining considerations for transferring clinical investigation oversight from one Institutional Review Board (IRB) to another, addressing regulatory responsibilities and procedures for clinical investigators and sponsors.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →